Study identifies clinical phenotype, visual outcomes of MOG-IgG antibody optic neuritis - Mayo Clinic
Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain | Acta Neuropathologica Communications | Full Text
Frontiers | Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease
Corrected CSF/Serum MOG-IgG Index, Lesion Location, and Clinical... | Download Scientific Diagram
Myelin-oligodendrocyte glycoprotein antibody-associated disease - The Lancet Neurology
Anti-MOG autoantibodies pathogenicity in children and macaques demyelinating diseases | Journal of Neuroinflammation | Full Text
Low mortality rate in a large cohort of myelin oligodendrocyte glycoprotein antibody disease (MOGAD) - Lotan - 2023 - Annals of Clinical and Translational Neurology - Wiley Online Library
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin – topic of research
IJMS | Free Full-Text | Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGAD
Myelin oligodendrocyte glycoprotein antibodies in neurological disease | Nature Reviews Neurology
SensoLyte® Anti-Mouse MOG (1-125) IgG Quantitative ELISA Kit Colorimetric - 1 kit
Selective Depletion of Antigen-Specific Antibodies for the Treatment of Demyelinating Disease - ScienceDirect
Neurological update: MOG antibody disease | SpringerLink
Brain Sciences | Free Full-Text | Coexistence of Myelin Oligodendrocyte Glycoprotein Immunoglobulin G and Neuronal or Glial Antibodies in the Central Nervous System: A Systematic Review
Diagnostic features of initial demyelinating events associated with serum MOG-IgG - ScienceDirect
Frontiers | MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder
Recent developments in MOG-IgG associated neurological disorders | Semantic Scholar
Frontiers | Age-Related Clinical Presentation of MOG-IgG Seropositivity in Israel
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations | Practical Neurology
Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder? | Neurology Neuroimmunology & Neuroinflammation
Frontiers | Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders?
Myelin oligodendrocyte glycoprotein immunoglobulin G‐associated disease: An overview - Fujihara - 2018 - Clinical and Experimental Neuroimmunology - Wiley Online Library
Frontiers | Positive Predictive Value of MOG-IgG for Clinically Defined MOG-AD Within a Real-World Cohort
Jacqueline Nicholas MD MPH on Twitter: "Differentiating MOG-IgG Associated #OpticNeuritis vs. #NeuromyelitisOptica Associated Optic Neuritis #OhioHealth MS https://t.co/xN9qBU4k3C" / Twitter
